Literature DB >> 23868899

AKI: a path forward.

Joseph V Bonventre1, David Basile, Kathleen D Liu, Dianne McKay, Bruce A Molitoris, Karl A Nath, Thomas L Nickolas, Mark D Okusa, Paul M Palevsky, Rick Schnellmann, Krystyna Rys-Sikora, Paul L Kimmel, Robert A Star.   

Abstract

The Kidney Research National Dialogue, supported by the National Institute of Diabetes and Digestive and Kidney Diseases, asked the scientific community to formulate and prioritize research objectives that would improve our understanding of kidney function and disease. High-priority objectives for AKI were identified, including enhancing training and collaborative opportunities, improving phenotyping and development of clinical tools, expanding our understanding of the pathophysiology and interaction between injury and reparative processes, and identifying determinants of long-term outcomes. Research in animal models must be translated to improve diagnosis and treatment of patients. The objectives identified by the Kidney Research National Dialogue provide the research community with future opportunities for improving the prevention, diagnosis, and treatment of people with AKI.

Entities:  

Mesh:

Year:  2013        PMID: 23868899      PMCID: PMC3805072          DOI: 10.2215/CJN.06040613

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  3 in total

1.  Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology.

Authors:  Paul M Palevsky; Bruce A Molitoris; Mark D Okusa; Adeera Levin; Sushrut S Waikar; Ron Wald; Glenn M Chertow; Patrick T Murray; Chirag R Parikh; Andrew D Shaw; Alan S Go; Sarah G Faubel; John A Kellum; Vernon M Chinchilli; Kathleen D Liu; Alfred K Cheung; Steven D Weisbord; Lakhmir S Chawla; James S Kaufman; Prasad Devarajan; Robert M Toto; Chi-yuan Hsu; Tom Greene; Ravindra L Mehta; John B Stokes; Aliza M Thompson; B Taylor Thompson; Christof S Westenfelder; James A Tumlin; David G Warnock; Sudhir V Shah; Yining Xie; Emily G Duggan; Paul L Kimmel; Robert A Star
Journal:  Clin J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 8.237

2.  Temporal changes in incidence of dialysis-requiring AKI.

Authors:  Raymond K Hsu; Charles E McCulloch; R Adams Dudley; Lowell J Lo; Chi-yuan Hsu
Journal:  J Am Soc Nephrol       Date:  2012-12-06       Impact factor: 10.121

Review 3.  Diagnosis, epidemiology and outcomes of acute kidney injury.

Authors:  Sushrut S Waikar; Kathleen D Liu; Glenn M Chertow
Journal:  Clin J Am Soc Nephrol       Date:  2008-03-12       Impact factor: 8.237

  3 in total
  23 in total

Review 1.  A basic science view of acute kidney injury biomarkers.

Authors:  Jennifer R Charlton; Didier Portilla; Mark D Okusa
Journal:  Nephrol Dial Transplant       Date:  2014-01-02       Impact factor: 5.992

2.  Nucleophosmin Phosphorylation as a Diagnostic and Therapeutic Target for Ischemic AKI.

Authors:  Zhiyong Wang; Erdjan Salih; Chinaemere Igwebuike; Ryan Mulhern; Ramon G Bonegio; Andrea Havasi; Steven C Borkan
Journal:  J Am Soc Nephrol       Date:  2019-01       Impact factor: 10.121

3.  Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.

Authors:  Jay L Koyner; Danielle L Davison; Ermira Brasha-Mitchell; Divya M Chalikonda; John M Arthur; Andrew D Shaw; James A Tumlin; Sharon A Trevino; Michael R Bennett; Paul L Kimmel; Michael G Seneff; Lakhmir S Chawla
Journal:  J Am Soc Nephrol       Date:  2015-02-05       Impact factor: 10.121

4.  Therapeutic Targets of Human AKI: Harmonizing Human and Animal AKI.

Authors:  Mark D Okusa; Mitchell H Rosner; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2015-10-30       Impact factor: 10.121

Review 5.  Challenges and advances in the treatment of AKI.

Authors:  Gur P Kaushal; Sudhir V Shah
Journal:  J Am Soc Nephrol       Date:  2014-01-30       Impact factor: 10.121

6.  Targeted inhibition of the type 2 cannabinoid receptor is a novel approach to reduce renal fibrosis.

Authors:  Lili Zhou; Shan Zhou; Peng Yang; Yuan Tian; Zhiwei Feng; Xiang-Qun Xie; Youhua Liu
Journal:  Kidney Int       Date:  2018-08-06       Impact factor: 10.612

7.  Urinary Matrix Metalloproteinase-7 Predicts Severe AKI and Poor Outcomes after Cardiac Surgery.

Authors:  Xiaobing Yang; Chunbo Chen; Siyuan Teng; Xiaorui Fu; Yan Zha; Huafeng Liu; Li Wang; Jianwei Tian; Xiangyan Zhang; Youhua Liu; Jing Nie; Fan Fan Hou
Journal:  J Am Soc Nephrol       Date:  2017-07-11       Impact factor: 10.121

8.  Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice.

Authors:  Satoko Arai; Kento Kitada; Tomoko Yamazaki; Ryosuke Takai; Xizhong Zhang; Yoji Tsugawa; Ryoichi Sugisawa; Ayaka Matsumoto; Mayumi Mori; Yasunori Yoshihara; Kent Doi; Natsumi Maehara; Shunsuke Kusunoki; Akiko Takahata; Eisei Noiri; Yusuke Suzuki; Naoki Yahagi; Akira Nishiyama; Lakshman Gunaratnam; Tomoko Takano; Toru Miyazaki
Journal:  Nat Med       Date:  2016-01-04       Impact factor: 53.440

9.  Ultrasound Modulates the Splenic Neuroimmune Axis in Attenuating AKI.

Authors:  Joseph C Gigliotti; Liping Huang; Amandeep Bajwa; Hong Ye; Eric H Mace; John A Hossack; Kambiz Kalantari; Tsuyoshi Inoue; Diane L Rosin; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

10.  Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment.

Authors:  Anitha Vijayan; Sarah Faubel; David J Askenazi; Jorge Cerda; William H Fissell; Michael Heung; Benjamin D Humphreys; Jay L Koyner; Kathleen D Liu; Girish Mour; Thomas D Nolin; Azra Bihorac
Journal:  Am J Kidney Dis       Date:  2016-03-04       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.